MH
Dr. Mayank Handa
Sun Pharma Industry Limited, Themis Medicare Ltd, NIPER-Raebareli, Eisai Pharmaceuticals India Pvt Ltd
Employment
-
Sun Pharma Industry Limited Research Manager II2023 - Present
-
Themis Medicare Ltd Executive Formulation R&D2018 - 2018
-
Eisai Pharmaceuticals India Pvt Ltd Management Trainee2017 - 2017
Education
-
NIPER-Raebareli Ph.D2018 - 2023
Projects & Funding
Projects & funding information is unavailable.
Publications (51)
- Arginine-vasopressin in the management of brain disorders: recent advancement and future perspective Save
- Zein decorated rifaximin nanosuspension: approach for sustained release and anti-bacterial efficacy enhancement Save
- USFDA-approved parenteral peptide formulations and excipients: Industrial perspective Save
- Combining donepezil and memantine via mannosylated PLGA nanoparticles for intranasal delivery: Characterization and preclinical studies Save
- Systematic optimization, characterization of Mycophenolic acid loaded nanostructured lipid carrier embedd ed nanogel for improved permeation and in vivo antipsoriatic activity Save
- Simultaneous Intranasal Codelivery of Donepezil and Memantine in a Nanocolloidal Carrier: Optimization, Pharmacokinetics, and Pharmacodynamics Studies Save
- Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals Save
- Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies Save
- Hybrid Nanomaterials as Novel Therapeutic and Imaging Modalities Save
- Nanoscaffolds and role of 3D-printed surgical dressings for wound healing application Save